Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for December 7th

Read MoreHide Full Article

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 7th:

Sprague Resources LP : This refined petroleum products and natural gas provider has witnessed the Zacks Consensus Estimate for its current year earnings increasing 54% over the last 60 days.

 

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 14.2%, compared with the industry average of 9.1%. Its five-year average dividend yield is 12.2%.

 

Sprague Resources LP Dividend Yield (TTM)

Sprague Resources LP Dividend Yield (TTM)

Sprague Resources LP dividend-yield-ttm | Sprague Resources LP Quote

 

AllianceBernstein Holding L.P. (AB - Free Report) : This investment manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.

 

This Zacks Rank #2 (Buy) company has a dividend yield of 8.3%, compared with the industry average of 1.8%. Its five-year average dividend yield is 8.9%.

 

Ellington Financial Inc. (EFC - Free Report) : This company that acquires and manages residential mortgage-backed securities has witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.3% over the last 60 days.

 

This Zacks Rank #2 company has a dividend yield of 8.0%, compared with the industry average of 0.0%. Its five-year average dividend yield is 10.9%.

 

Ellington Financial Inc. Dividend Yield (TTM)

Ellington Financial Inc. Dividend Yield (TTM)

Ellington Financial Inc. dividend-yield-ttm | Ellington Financial Inc. Quote

 

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


AllianceBernstein Holding L.P. (AB) - free report >>

Ellington Financial Inc. (EFC) - free report >>

Published in